Cargando…
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457196/ https://www.ncbi.nlm.nih.gov/pubmed/37532787 http://dx.doi.org/10.1038/s41375-023-01983-0 |
| _version_ | 1785096869997707264 |
|---|---|
| author | Chemlal, Djamila Varlet, Emmanuel Machura, Amelie Ovejero, Sara Requirand, Guilhem Robert, Nicolas Cartron, Guillaume Alaterre, Elina Bret, Caroline Vincent, Laure Herbaux, Charles Cavalli, Giacomo Bruyer, Angélique De Boussac, Hugues Moreaux, Jerome |
| author_facet | Chemlal, Djamila Varlet, Emmanuel Machura, Amelie Ovejero, Sara Requirand, Guilhem Robert, Nicolas Cartron, Guillaume Alaterre, Elina Bret, Caroline Vincent, Laure Herbaux, Charles Cavalli, Giacomo Bruyer, Angélique De Boussac, Hugues Moreaux, Jerome |
| author_sort | Chemlal, Djamila |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10457196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104571962023-08-27 EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma Chemlal, Djamila Varlet, Emmanuel Machura, Amelie Ovejero, Sara Requirand, Guilhem Robert, Nicolas Cartron, Guillaume Alaterre, Elina Bret, Caroline Vincent, Laure Herbaux, Charles Cavalli, Giacomo Bruyer, Angélique De Boussac, Hugues Moreaux, Jerome Leukemia Letter Nature Publishing Group UK 2023-08-02 2023 /pmc/articles/PMC10457196/ /pubmed/37532787 http://dx.doi.org/10.1038/s41375-023-01983-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Chemlal, Djamila Varlet, Emmanuel Machura, Amelie Ovejero, Sara Requirand, Guilhem Robert, Nicolas Cartron, Guillaume Alaterre, Elina Bret, Caroline Vincent, Laure Herbaux, Charles Cavalli, Giacomo Bruyer, Angélique De Boussac, Hugues Moreaux, Jerome EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title | EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title_full | EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title_fullStr | EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title_full_unstemmed | EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title_short | EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma |
| title_sort | ezh2 targeting induces cd38 upregulation and response to anti-cd38 immunotherapies in multiple myeloma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457196/ https://www.ncbi.nlm.nih.gov/pubmed/37532787 http://dx.doi.org/10.1038/s41375-023-01983-0 |
| work_keys_str_mv | AT chemlaldjamila ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT varletemmanuel ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT machuraamelie ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT ovejerosara ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT requirandguilhem ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT robertnicolas ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT cartronguillaume ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT alaterreelina ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT bretcaroline ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT vincentlaure ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT herbauxcharles ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT cavalligiacomo ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT bruyerangelique ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT deboussachugues ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma AT moreauxjerome ezh2targetinginducescd38upregulationandresponsetoanticd38immunotherapiesinmultiplemyeloma |